Operating Income: The income after operating expenses.
PMV Pharmaceuticals, Inc. (PMVP) had Operating Income of $-18.88M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-18.09M |
|
-- |
|
-- |
|
$18.88M |
|
|
Operating Income |
$-18.88M |
$0.80M |
|
$-18.08M |
|
$-18.08M |
|
$-18.09M |
|
$-18.09M |
|
$-18.09M |
|
$-18.09M |
|
$-18.88M |
|
$-19.24M |
|
53.39M |
|
53.39M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$81.41M |
|
$0.15M |
|
$0.66M |
|
$82.07M |
|
$10.57M |
|
-- |
|
-- |
|
$10.57M |
|
$71.50M |
|
$71.50M |
|
$71.50M |
|
53.46M |
|
| Cash Flow Statement Financials | |
$-34.26M |
|
$8.60M |
|
$0.14M |
|
$37.98M |
|
$12.47M |
|
$-25.51M |
|
$2.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.30% |
|
-25.30% |
|
-22.04% |
|
-25.30% |
|
$1.34 |
|
$-0.64 |
|
$-0.64 |
|